University of California San Diego at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of California San Diego brings 2 presentations to AMP 2026 in Seattle. Its sessions centre on artificial intelligence in solid tumor testing and in training. Topics include detecting homologous recombination deficiency using genomic and AI-based approaches, and a demonstration of AI in trainee education.
| Organization | AMP 2026 Attendance |
|---|---|
University of California San Diego La Jolla, CA | |
Public research university in La Jolla with genomics and bioinformatics research and an affiliated academic health system. | Talk Thu, Nov 12 10:15am–10:45am Detecting Homologous Recombination Deficiency with Genomic and AI-Based Approaches Two lab methods for homologous recombination deficiency: one reads genomic mutation patterns, the other infers it from H&E slides with AI. Workshop Thu, Nov 12 12:40pm–1:10pm AI in Trainee Education: A Demonstration and Discussion Building a large language model study aid for pathology trainees, alongside survey findings on how trainees and educators use AI. |
Instantly find 20 buyers from University of California San Diego
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction